Attentional Bias in Body Dysmorphic Disorder

Completed

• Conditions: Body Dysmorphic Disorders

• Registration Number: NCT01398904
• Lead Sponsor: Massachusetts General Hospital

Brief Summary

Body Dysmorphic Disorder (BDD) participants will demonstrate greater attentional biases as compared to healthy control (HC) participants. Greater attention bias will be associated with greater distress. Greater attention bias will be associated with greater symptom severity.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-03
• Study First Submitted: 2011-07-15
• Study First Submitted QC: 2011-07-19
• Study First Posted: 2011-07-21
• Primary Completion: 2012-07
• Study Completion: 2012-07
• Status Verified: 2014-12
• Last Update Submitted: 2014-12-02
• Last Update Posted: 2014-12-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

Not provided

Exclusion Criteria

• Major medical or neurological conditions
• schizophrenia, schizoaffective disorder, or any other current lifetime DSM-IV psychotic disorder that is not attributable to delusional BDD
• current suicidality
• current homicidality

Exclusion criteria for healthy controls:

• Any current Axis I psychiatric illness
• history of BDD

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Attention Pattern	Day 2	Gaze tracking via an Eyelink II eye tracker will determine perception of visual information.

Secondary Outcome Measures

Name	Time	Method
Facial Attractiveness	Day 2	Using a 9-point Likert scale, participants will rate the perceived most attractive and unattractive feature of their own and the control face.
Subjective Units of Distress Scale (SUDS)	Day 2	Participants will provide a distress score based on the facial images observed.

Trial Locations

Locations (1)

Massachusetts General Hospital; 🇺🇸 Boston, Massachusetts, United States